Judy Young - Concepedia

Author

Judy Young

University of California, Los Angeles

Also Known As

J C Young, J.C. Young, Joyce Yeung, Judy C Young, Judy C. Young, Judy Young

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

University of California, Los Angeles Molecular Oncology (United States)Howard Hughes Medical Institute University of California, San Francisco Novartis (United States)

About

Judy Young is an author at University of California, Los Angeles specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	1.1K
2	Natural Sciences	2	2	355
3	Health Sciences	1	1	14
4	Biochemistry	1	1	97
5	Biology	1	1	258

Judy Young

Publications

Citations

H-Index

Page 1

	Year	Citations
BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Alexander J. Muller, Judy Young, Ann Marie Pendergast, Molecular and Cellular Biology Hematological MalignancyChromatinSignal TransductionCell RegulationOncogenic Agent	1991	386
Anti-CD20/CD3 T cell–dependent bispecific antibody for the treatment of B cell malignancies Liping Sun, Diego Ellerman, Mary Mathieu, Science Translational Medicine	2015	269
Identification of transferred DNA insertions within Arabidopsis genes involved in signal transduction and ion transport. Patrick J. Krysan, Judy Young, Frans E. Tax, Proceedings of the National Academy of Sciences Plant GeneticsSequenced Arabidopsis GeneGeneticsMolecular BiologyMolecular Genetics	1996	258
Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent Mark Merchant, Xiaolei Ma, Henry R. Maun, Proceedings of the National Academy of Sciences	2013	239
Antibody-drug conjugates targeted to CD79 for the treatment of non-Hodgkin lymphoma Andrew G. Polson, Shang‐Fan Yu, Kristi Elkins, Blood	2007	168
Thrombopoietin, flt3, and kit ligands together suppress apoptosis of human mobilized CD34+ cells and recruit primitive CD34+Thy-1+ cells into rapid division Lesley Murray, Judy Young, Linda J. Osborne, Experimental Hematology ThrombopoiesisRapid DivisionT-regulatory CellApoptosisImmunology	1999	124
Lead Optimization of a 4-Aminopyridine Benzamide Scaffold To Identify Potent, Selective, and Orally Bioavailable TYK2 Inhibitors Jun Liang, Anne van Abbema, Mercedesz Balázs, Journal of Medicinal Chemistry Pharmaceutical ResearchImmunologyLead IdentificationPharmacotherapyPre-clinical Pharmacology	2013	97
<i>BCR</i> First Exon Sequences Specifically Activate the <i>BCR/ABL</i> Tyrosine Kinase Oncogene of Philadelphia ChromosomePositive Human Leukemias Alexander J. Muller, Judy Young, Ann Marie Pendergast, Molecular and Cellular Biology Hematological MalignancySignal TransductionCell RegulationOncogenic AgentReceptor Tyrosine Kinase	1991	97
Selective Transformation of Primitive Lymphoid Cells by the <i>BCR</i> / <i>ABL</i> Oncogene Expressed in Long-Term Lymphoid or Myeloid Cultures Judy Young, Owen N. Witte Molecular and Cellular Biology	1988	77
Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal Judy Young, Spencer Wu, Gun Hansteen, Cytotherapy ChromatinHistone DeacetylasesChromatin RemodelingMedicineStem Cell Mobilization	2004	67

Page 1